Clinical Trial Update: Oritavancin for CIED Infections With MDR Gram-positive Cocci [NA]

View source ↗

Summary

A clinical trial update describes using oritavancin for cardiac implantable electronic device infections caused by multidrug-resistant Gram-positive cocci, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Implantable Electronic Device Infection
• Infective Endocarditis

Drugs mentioned

• Orbactiv (oritavancin)

Snippet

Sponsor: Medical University of Silesia | Conditions: Cardiac Implantable Electronic Device Infections, Infective Endocarditis | NA | Status: NOT_YET_RECRUITING